* Definitive Healthcare Corp DH.OQ DH.O is expected
to show a
rise in quarterly revenue when it reports results on August
14.
* The Framingham Massachusetts-based company is expected to
report a 11.9% increase in revenue to $61.021 million from
$54.55 million a year ago, according to the mean estimate from
13 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Definitive
Healthcare
Corp is for earnings of 6 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Definitive
Healthcare Corp is $13, above its last closing price
of $10.55.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.05 0.04 0.06 Beat 35
Dec. 31 2023 0.04 0.04 0.07 Beat 67.7
Sep. 30 2022 0.05 0.05 0.06 Beat 27.7
Jun. 30 2022 0.05 0.05 0.06 Beat 18.3
Mar. 0.03 0.03 0.05 Beat 44.9
31 2022
Dec. 31 2021 0.04 0.04 0.04 Met -7.4
Sep. 30 2021 0.02 0.02 0.01 Missed -47.4
This summary was machine generated August 12 at 01:14 GMT. All
figures in US dollars unless otherwise stated